Trial Profile
Study on Mastocytosis for Rupatadine Treatment An Exploratory Phase IV, Randomised, Double-blind, Placebo Controlled Crossover Study to Assess the Efficacy of 20 mg Rupatadine
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rupatadine (Primary)
- Indications Mastocytosis
- Focus Therapeutic Use
- Acronyms SMART
- 23 Aug 2013 New trial record